Cannassure Therapeutics (Israel) Price on October 7, 2024
CSURE Stock | 950.00 118.00 11.05% |
If you're considering investing in Cannassure Stock, it is important to understand the factors that can impact its price. As of today, the current price of Cannassure Therapeutics stands at 950.00, as last reported on the 11th of December 2024, with the highest price reaching 1,049 and the lowest price hitting 930.00 during the day. Cannassure Therapeutics secures Sharpe Ratio (or Efficiency) of -0.081, which signifies that the company had a -0.081% return per unit of risk over the last 3 months. Cannassure Therapeutics exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Cannassure Therapeutics' Mean Deviation of 4.53, standard deviation of 9.02, and Risk Adjusted Performance of (0.05) to double-check the risk estimate we provide.
Cannassure Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Cannassure |
Sharpe Ratio = -0.081
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | CSURE |
Estimated Market Risk
9.02 actual daily | 80 80% of assets are less volatile |
Expected Return
-0.73 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.08 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Cannassure Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Cannassure Therapeutics by adding Cannassure Therapeutics to a well-diversified portfolio.
Cannassure Therapeutics Valuation on October 7, 2024
It is possible to determine the worth of Cannassure Therapeutics on a given historical date. On October 7, 2024 Cannassure was worth 1621.0 at the beginning of the trading date compared to the closed value of 1621.0. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Cannassure Therapeutics stock. Still, in general, we apply an absolute valuation method to find Cannassure Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Cannassure Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Cannassure Therapeutics' related companies.
Open | High | Low | Close | Volume | |
1,621 | 1,621 | 1,621 | 1,621 | 1.00 | |
10/07/2024 | 1,621 | 1,621 | 1,621 | 1,621 | 1.00 |
1,621 | 1,621 | 1,621 | 1,621 | 1.00 |
Backtest Cannassure Therapeutics | | | Cannassure Therapeutics History | | | Cannassure Therapeutics Valuation | Previous | Next |
Cannassure Therapeutics Trading Date Momentum on October 7, 2024
On October 08 2024 Cannassure Therapeutics was traded for 1,621 at the closing time. The highest price during the trading period was 1,621 and the lowest recorded bid was listed for 1,621 . There was no trading activity during the period 1.0. Lack of trading volume on October 8, 2024 did not affect price variability. The overall trading delta to the current price is 0.00% . |
Cannassure Therapeutics Fundamentals Correlations and Trends
By evaluating Cannassure Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Cannassure Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Cannassure financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Cannassure Therapeutics Stock history
Cannassure Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Cannassure is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Cannassure Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Cannassure Therapeutics stock prices may prove useful in developing a viable investing in Cannassure Therapeutics
Cannassure Therapeutics Stock Technical Analysis
Cannassure Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Cannassure Therapeutics Period Price Range
Low | December 11, 2024
| High |
0.00 | 0.00 |
Cannassure Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on Tel Aviv Stock Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Cannassure Therapeutics December 11, 2024 Market Strength
Market strength indicators help investors to evaluate how Cannassure Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Cannassure Therapeutics shares will generate the highest return on investment. By undertsting and applying Cannassure Therapeutics stock market strength indicators, traders can identify Cannassure Therapeutics entry and exit signals to maximize returns
Cannassure Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Cannassure Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Cannassure Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Cannassure to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | (0.05) | |||
Jensen Alpha | (0.73) | |||
Total Risk Alpha | (2.17) | |||
Treynor Ratio | 12.51 |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Additional Tools for Cannassure Stock Analysis
When running Cannassure Therapeutics' price analysis, check to measure Cannassure Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cannassure Therapeutics is operating at the current time. Most of Cannassure Therapeutics' value examination focuses on studying past and present price action to predict the probability of Cannassure Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cannassure Therapeutics' price. Additionally, you may evaluate how the addition of Cannassure Therapeutics to your portfolios can decrease your overall portfolio volatility.